Clinical Trial Update: Neoadjuvant Low-Dose Radiotherapy Combined With Adebrelimab and Single-Agent Albumin-Bound Paclitaxel Chemotherapy for Early-Stage Oral Squamous Cell Carcinoma: A Prospective, Single-Arm Clinical Trial [Phase 2]

View source ↗

Summary

A Phase 2 single-arm trial is evaluating neoadjuvant low-dose radiotherapy in combination with adebrelimab and albumin-bound paclitaxel for early-stage oral squ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Jun Jia | Conditions: Early-Stage Oral Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING